Cognis’ Omevital™ Omega-3 Earns ‘Superior Taste Award’ from the International Taste & Quality Institute

June 29, 2008, New Orleans, La. – The International Taste & Quality Institute, iTQi, Brussels, recently presented the 2008 “Superior Taste Awards” for three Omevital™ Omega-3 products to Napro Pharma, a Cognis subsidiary that specializes in the manufacture of these marine sourced, health-enhancing ingredients for the nutrition industry. This is the second time the iTQi has recognized Napro Pharma for its superior tasting flavored Omega-3.

The International Taste & Quality Institute, iTQi, Brussels, is the leading independent Chef- and Sommelier- based organization dedicated to “judging, honoring and promoting superior tasting food and drink from around the world.”
“It’s one thing to say your product is characterized by its superior sensory profile, but this award from outside global experts provides invaluable perspective for our customers,” said Robert Bailey, Marketing Manager, Cognis Nutrition & Health. He explained that the Omevital™ line of marine-sourced Omega-3 fatty acids have no fishy taste or odor and no reflux after intake (“fish oil repeat”). The formulations are tailor-made to specific customer needs and can also be flavored or blended with other ingredients. All products are harvested from sustainable and renewable, cold-water deep sea marine sources. Manufacturing is done under full compliance with all GMP standards and includes extensive quality testing throughout the process.

Omevital™ Omega-3 fatty acids are marine-sourced and thus excellent sources of EPA and DHA. The fatty acids EPA and DHA provide significantly more health benefits than plant-based Omega-3 containing only ALA. The fatty acid ALA must be converted to EPA and DHA before it can be used by the human body. Due to ALA’s inefficient conversion rate (approximately 2%), consumption levels must be unrealistically high to achieve the desired health benefits. Cognis’ Omevital™ product line delivers all the nutritional value of marine-sourced Omega-3 combined with an award-winning sensory profile.

Omega-3 fatty acids are one of the fastest growing nutritional ingredients, mainly due to the high level of consumer awareness of the health benefits of Omega-3 EPA and DHA. Recent market analysis has forecasted that Omega-3 fortified foods could exceed $8 billion in retail sales. Cognis is well equipped to support customers in the development of functional foods fortified with the multiple health benefits of Omega-3. Cognis will be featuring the Omevital™ product line at the 2008 IFT Food Expo as part of their overall focus on heart healthy functional foods.

Cognis markets their Omevital™ products for the North American dietary supplement industry exclusively through Marine Nurticeutical Corporation.

For more information about Omevital™ omega-3 fatty acids or to place an order, visit, call 800.673.3702, e-mail [email protected], or fax 513.482.3576.

About Cognis:

Cognis ( is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,600 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The subsidiary Pulcra Chemicals offers specialized chemical products and process expertise to customers in the fiber, textile, and leather industries. Cognis also holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of oleochemicals.

Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2007, Cognis recorded sales of about 3.52 billion euros and an Adjusted EBITDA (operating result) of 410 million euros.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.